Results 111 to 120 of about 60,626 (311)

Changes in Daily Urinary Excretion of Follicle-stimulating and Luteinizing Hormones Caused by Ethinyl-estradiol and Conjugated Equine Estrogens (Premarin) in Low Doses

, 1969
Atsushi Saito, Mineko Fukushima
openalex   +2 more sources

Gonadal-Hypothalamic Interaction in Prepubertal and Pubertal Man: Effect of Clomiphene Citrate on Urinary Follicle-Stimulating Hormone and Luteinizing Hormone and Plasma Testosterone [PDF]

, 1972
Howard E. Kulin, Melvin M. Grumbach, Selna L. Kaplan   +2 more
openalex   +1 more source

Systematic review and meta‐analysis of COVID‐19 association with human semen quality: Changes in semen parameters pre‐ and post‐COVID

UroPrecision, EarlyView.
Abstract Coronavirus disease (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which may infect the cells through binding with the angiotensin‐converting enzyme 2 (ACE2) receptors that can also be found in the male reproductive organs.
Wempy Supit, Tommy Supit, Sherryn Sherryn   +2 more
wiley   +1 more source

Suppression of the Pituitary Follicle-Stimulating Hormone Secretion during Proestrus and Estrus in Rats by Porcine Follicular Fluid: Possible Site of Action* [PDF]

, 1979
Louis V. DePaolo, Phyllis M. Wise, Larry Anderson, Charles A. Barraclough, Cornelia P. Channing   +4 more
openalex   +1 more source

Pituitary apoplexy is associated with concurrent or subsequent diagnosis of human immunodeficiency virus

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objective Pituitary apoplexy (PA) is a rare condition caused by hemorrhage or infarction of the pituitary gland with associated risk of cranial neuropathies, endocrinopathies, and even death. Human immunodeficiency virus (HIV) has been shown to have some association with pituitary apoplexy, however, large‐scale studies have not been performed.
Jennifer E. Douglas, Mandy K. Salmon, Rijul S. Kshirsagar, Jacob G. Eide, Caitlin White, Julia Kharlip, Christina Jackson, John Y. K. Lee, Daniel Yoshor, Michael A. Kohanski, James N. Palmer, Nithin D. Adappa   +11 more
wiley   +1 more source

Follicle-Stimulating Hormone-Producing Pituitary Adenoma: A Case Report and Review of the Literature

AACE Clinical Case Reports, 2019
: Objective: To describe an unusual presentation of a follicle-stimulating hormone-secreting pituitary adenoma leading to ovarian hyperstimulation syndrome.
Sonal Patel, BS, Donato Pacione, MD, Ilene Fischer, MD, Ekrem Maloku, MD, Nidhi Agrawal, MD   +4 more
doaj  

Purification of Follicle-stimulating Hormone from Human Pituitary Glands

, 1967
B.B. Saxena, P. Rathnam
openalex   +1 more source

Addressing Demographic Challenges Through Public–Private Partnerships: In Vitro Fertilization in Latvia

World Medical &Health Policy, EarlyView.
ABSTRACT The study by Morshed‐Behbahani et al. highlights that financial barriers are not the sole obstacle to accessing infertility treatment. To ensure equal access for all, infertility treatment should be regarded as a universal human right, with the public sector assuming responsibility for its provision.
Arturs Kalva, Girts Brigis
wiley   +1 more source

Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial

The Journal of Dermatology, EarlyView.
ABSTRACT Telogen effluvium (TE) is an acute and diffuse hair loss due to an abnormal increase in telogen hair follicles in response to external or internal factors. Recently, TE attracts global interest as a major cause of hair loss as a sequela of COVID‐19.
Manabu Ohyama, Ryokichi Irisawa, Masaki Uchiyama, Miho Mori, Kazuhiro Aoki, Yuto Ueda, Toru Fujita   +6 more
wiley   +1 more source

Editorial: Follicle-stimulating hormone: Fertility and beyond-volume II

Frontiers in Endocrinology, 2022
Manuela Simoni, Ilpo Huhtaniemi, Livio Casarini, Daniele Santi   +3 more
doaj   +1 more source